The prevalence of BRCA1/2 mutation carriers in general population is around 0.2%, and about 5%–10% of all breast cancers and 10%–15% of ovarian cancer cases can be attributed to this risk factor [11]. The gene discussed is BRCA1; the disease is ovarian cancer.